Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)

China flag China · Delayed Price · Currency is CNY
24.02
-1.35 (-5.32%)
Jul 30, 2026, 3:04 PM CST
Market Cap3.32B -42.2%
Revenue (ttm)543.82M -19.3%
Net Income-240.38M
EPS-1.83
Shares Out 130.89M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,823,008
Open25.98
Previous Close25.37
Day's Range23.94 - 25.98
52-Week Range22.58 - 61.76
Beta-0.29
Analystsn/a
Price Targetn/a
Earnings DateAug 24, 2026

About SHE:300683

Wuhan Hiteck Biological Pharma Co.,Ltd, a biopharmaceutical company, engages in the production and sales of bioengineering products and lyophilized powder injections in China and internationally. The company operates through Biopharmaceutical Division; Pharmaceutical Technology Services Division; In Vitro Diagnostic Reagents Division; Production and Sales Division of Active Pharmaceutical Ingredients and Pharmaceutical Intermediates; and Other Divisions segments. Its products include Epramine for injection; mouse nerve growth factor for injecti... [Read more]

Sector Healthcare
Founded 1992
Employees 958
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300683
Full Company Profile

Financial Performance

In 2025, SHE:300683's revenue was 541.45 million, a decrease of -16.57% compared to the previous year's 648.97 million. Losses were -231.27 million, 233.5% more than in 2024.

Financial Statements